References
- Abdelhaleem, M. (2004). Do human RNA helicases have a role in cancer? Biochim. Biophys. Acta 1704, 37-46.
- Adamson, D.C., Shi, Q., Wortham, M., Northcott, P.A., Di, C., Duncan, C.G., Li, J., McLendon, R.E., Bigner, D.D., Taylor, M.D., et al. (2010). OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Cancer Res. 70, 181-191. https://doi.org/10.1158/0008-5472.CAN-09-2331
- Ashour, A.E., Jamal, S., Cheryan, V.T., Muthu, M., Zoheir, K.M., Alafeefy, A.M., Abd-Allah, A.R., Levi, E., Tarca, A.L., Polin, L.A., et al. (2013). CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth. PLoS One 8, e66733. https://doi.org/10.1371/journal.pone.0066733
- Baltz, A.G., Munschauer, M., Schwanhausser, B., Vasile, A., Murakawa, Y., Schueler, M., Youngs, N., Penfold-Brown, D., Drew, K., Milek, M., et al. (2012). The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol. Cell 46, 674-690. https://doi.org/10.1016/j.molcel.2012.05.021
- Battelli, C., Nikopoulos, G.N., Mitchell, J.G., and Verdi, J.M. (2006). The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol. Cell Neurosci. 31, 85-96. https://doi.org/10.1016/j.mcn.2005.09.003
- Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B.M., Strein, C., Davey, N.E., Humphreys, D.T., Preiss, T., Steinmetz, L.M., et al. (2012). Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393-1406. https://doi.org/10.1016/j.cell.2012.04.031
- Castello, A., Fischer, B., Hentze, M.W., and Preiss, T. (2013). RNAbinding proteins in Mendelian disease. Trends Genet. 29, 318-327. https://doi.org/10.1016/j.tig.2013.01.004
- CBTRUS (2012). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008 (March 23, 2012 Revision). Hinsdale, IL, Central Brain Tumor Registry of the United States.
- Cho, Y.J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., Berhoukim, R., Amani, V., Goumnerova, L., Eberhart, C.G., et al. (2011). Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 29, 1424-1430. https://doi.org/10.1200/JCO.2010.28.5148
- Choi, Y.J., and Lee, S.G. (2012). The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export. J. Cell Biochem. 113, 985-996. https://doi.org/10.1002/jcb.23428
- Clark, J., Lu, Y.J., Sidhar, S.K., Parker, C., Gill, S., Smedley, D., Hamoudi, R., Linehan, W.M., Shipley, J., and Cooper, C.S. (1997). Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15, 2233-2239. https://doi.org/10.1038/sj.onc.1201394
- Clifford, S.C., Lusher, M.E., Lindsey, J.C., Langdon, J.A., Gilbertson, R.J., Straughton, D., and Ellison, D.W. (2006). Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 5, 2666-2670. https://doi.org/10.4161/cc.5.22.3446
- Cruciat, C.M., Dolde, C., de Groot, R.E., Ohkawara, B., Reinhard, C., Korswagen, H.C., and Niehrs, C. (2013). RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling. Science 339, 1436-1441. https://doi.org/10.1126/science.1231499
- Daugeron, M.C., and Linder, P. (1998). Dbp7p, a putative ATPdependent RNA helicase from Saccharomyces cerevisiae, is required for 60S ribosomal subunit assembly. RNA 4, 566-581. https://doi.org/10.1017/S1355838298980190
- Di, C., Liao, S., Adamson, D.C., Parrett, T.J., Broderick, D.K., Shi, Q., Lengauer, C., Cummins, J.M., Velculescu, V.E., Fults, D.W., et al. (2005). Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res. 65, 919-924.
- Dubuc, A.M., Remke, M., Korshunov, A., Northcott, P.A., Zhan, S.H., Mendez-Lago, M., Kool, M., Jones, D.T., Unterberger, A., Morrissy, A.S., et al. (2013). Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol. 125, 373-384. https://doi.org/10.1007/s00401-012-1070-9
- Epple, L.M., Griffiths, S.G., Dechkovskaia, A.M., Dusto, N.L., White, J., Ouellette, R.J., Anchordoquy, T.J., Bemis, L.T., and Graner, M.W. (2012). Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS One 7, e42064. https://doi.org/10.1371/journal.pone.0042064
- Fan, X., and Eberhart, C.G. (2008). Medulloblastoma stem cells. J. Clin. Oncol. 26, 2821-2827. https://doi.org/10.1200/JCO.2007.15.2264
- Fogarty, M.P., Kessler, J.D., and Wechsler-Reya, R.J. (2005). Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J. Neurobiol. 64, 458-475. https://doi.org/10.1002/neu.20166
- Forbes, S.A., Bindal, N., Bamford, S., Cole, C., Kok, C.Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011). COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res. 39, D945-950. https://doi.org/10.1093/nar/gkq929
- Francois, S., D'rlando, C., Fatone, T., Touvier, T., Pessina, P., Meneveri, R., and Brunelli, S. (2012). Necdin enhances myoblasts survival by facilitating the degradation of the mediator of apoptosis CCAR1/CARP1. PLoS One 7, e43335. https://doi.org/10.1371/journal.pone.0043335
- Frange, P., Alapetite, C., Gaboriaud, G., Bours, D., Zucker, J.M., Zerah, M., Brisse, H., Chevignard, M., Mosseri, V., Bouffet, E., et al. (2009). From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000). J. Neurooncol. 95, 271-279. https://doi.org/10.1007/s11060-009-9927-z
- Fukawa, T., Ono, M., Matsuo, T., Uehara, H., Miki, T., Nakamura, Y., Kanayama, H.O., and Katagiri, T. (2012). DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas. Cancer Res. 72, 5867-5877. https://doi.org/10.1158/0008-5472.CAN-12-1645
- Galante, P.A., Sandhu, D., de Sousa Abreu, R., Gradassi, M., Slager, N., Vogel, C., de Souza, S.J., and Penalva, L.O. (2009). A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation. RNA Biol. 6, 426-433. https://doi.org/10.4161/rna.6.4.8841
- Geissler, R., Golbik, R.P., and Behrens, S.E. (2012). The DEADbox helicase DDX3 supports the assembly of functional 80S ribosomes. Nucleic Acids Res. 40, 4998-5011. https://doi.org/10.1093/nar/gks070
- Gibson, P., Tong, Y., Robinson, G., Thompson, M.C., Currle, D.S., Eden, C., Kranenburg, T.A., Hogg, T., Poppleton, H., Martin, J., et al. (2010). Subtypes of medulloblastoma have distinct developmental origins. Nature 468, 1095-1099. https://doi.org/10.1038/nature09587
- Glisovic, T., Bachorik, J.L., Yong, J., and Dreyfuss, G. (2008). RNAbinding proteins and post-transcriptional gene regulation. FEBS Lett. 582, 1977-1986. https://doi.org/10.1016/j.febslet.2008.03.004
- Hambardzumyan, D., Becher, O.J., and Holland, E.C. (2008a). Cancer stem cells and survival pathways. Cell Cycle 7, 1371-1378. https://doi.org/10.4161/cc.7.10.5954
- Hambardzumyan, D., Becher, O.J., Rosenblum, M.K., Pandolfi, P.P., Manova-Todorova, K., and Holland, E.C. (2008b). PI3K path- way regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev. 22, 436-448. https://doi.org/10.1101/gad.1627008
- Horisawa, K., Imai, T., Okano, H., and Yanagawa, H. (2009). 3'- Untranslated region of doublecortin mRNA is a binding target of the Musashi1 RNA-binding protein. FEBS Lett. 583, 2429-2434. https://doi.org/10.1016/j.febslet.2009.06.045
- Hunter, S., Jones, P., Mitchell, A., Apweiler, R., Attwood, T.K., Bateman, A., Bernard, T., Binns, D., Bork, P., Burge, S., et al. (2012). InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res. 40, D306-312. https://doi.org/10.1093/nar/gkr948
- Imai, T., Tokunaga, A., Yoshida, T., Hashimoto, M., Mikoshiba, K., Weinmaster, G., Nakafuku, M., and Okano, H. (2001). The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol. Cell Biol. 21, 3888-3900. https://doi.org/10.1128/MCB.21.12.3888-3900.2001
- Jones, D.T., Jager, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.J., Pugh, T.J., Hovestadt, V., Stutz, A.M., et al. (2012). Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100-105. https://doi.org/10.1038/nature11284
- Jorba, N., Juarez, S., Torreira, E., Gastaminza, P., Zamarreno, N., Albar, J.P., and Ortin, J. (2008). Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 8, 2077-2088. https://doi.org/10.1002/pmic.200700508
- Kaderali, Z., Lamberti-Pasculli, M., and Rutka, J.T. (2009). The changing epidemiology of paediatric brain tumours: a review from the Hospital for Sick Children. Childs Nerv. Syst. 25, 787-793. https://doi.org/10.1007/s00381-008-0771-9
- Kawauchi, D., Robinson, G., Uziel, T., Gibson, P., Rehg, J., Gao, C., Finkelstein, D., Qu, C., Pounds, S., Ellison, D.W., et al. (2012). A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 21, 168-180. https://doi.org/10.1016/j.ccr.2011.12.023
- Kayahara, T., Sawada, M., Takaishi, S., Fukui, H., Seno, H., Fukuzawa, H., Suzuki, K., Hiai, H., Kageyama, R., Okano, H., et al. (2003). Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett. 535, 131-135. https://doi.org/10.1016/S0014-5793(02)03896-6
- Kim, J.H., Yang, C.K., Heo, K., Roeder, R.G., An, W., and Stallcup, M.R. (2008). CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol. Cell 31, 510-519. https://doi.org/10.1016/j.molcel.2008.08.001
- Klass, D.M., Scheibe, M., Butter, F., Hogan, G.J., Mann, M., and Brown, P.O. (2013). Quantitative proteomic analysis reveals concurrent RNA-protein interactions and identifies new RNAbinding proteins in Saccharomyces cerevisiae. Genome Res. 23, 1028-1038. https://doi.org/10.1101/gr.153031.112
- Kolobova, E., Efimov, A., Kaverina, I., Rishi, A.K., Schrader, J.W., Ham, A.J., Larocca, M.C., and Goldenring, J.R. (2009). Microtubule-dependent association of AKAP350A and CCAR1 with RNA stress granules. Exp. Cell Res. 315, 542-555. https://doi.org/10.1016/j.yexcr.2008.11.011
- Kong, D.S., Kim, M.H., Park, W.Y., Suh, Y.L., Lee, J.I., Park, K., Kim, J.H., and Nam, D.H. (2008). The progression of gliomas is associated with cancer stem cell phenotype. Oncol. Rep. 19, 639-643.
- Kool, M., Koster, J., Bunt, J., Hasselt, N.E., Lakeman, A., van Sluis, P., Troost, D., Meeteren, N.S., Caron, H.N., Cloos, J., et al. (2008). Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3, e3088. https://doi.org/10.1371/journal.pone.0003088
- Kool, M., Korshunov, A., Remke, M., Jones, D.T., Schlanstein, M., Northcott, P.A., Cho, Y.J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012). Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 123, 473-484. https://doi.org/10.1007/s00401-012-0958-8
- Kuwako, K., Kakumoto, K., Imai, T., Igarashi, M., Hamakubo, T., Sakakibara, S., Tessier-Lavigne, M., Okano, H.J., and Okano, H. (2010). Neural RNA-binding protein Musashi1 controls midline crossing of precerebellar neurons through posttranscriptional regulation of Robo3/Rig-1 expression. Neuron 67, 407-421. https://doi.org/10.1016/j.neuron.2010.07.005
- Kwong, A.D., Rao, B.G., and Jeang, K.T. (2005). Viral and cellular RNA helicases as antiviral targets. Nat. Rev. Drug Discov. 4, 845-853. https://doi.org/10.1038/nrd1853
- Lai, M.C., Lee, Y.H., and Tarn, W.Y. (2008). The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control. Mol. Biol. Cell 19, 3847-3858. https://doi.org/10.1091/mbc.E07-12-1264
- Lai, M.C., Chang, W.C., Shieh, S.Y., and Tarn, W.Y. (2010). DDX3 regulates cell growth through translational control of cyclin E1. Mol. Cell. Biol. 30, 5444-5453. https://doi.org/10.1128/MCB.00560-10
- Lane, D. (1988). Enlarged family of putative helicases. Nature 334, 478.
- Lee, M.J., Hatton, B.A., Villavicencio, E.H., Khanna, P.C., Friedman, S.D., Ditzler, S., Pullar, B., Robison, K., White, K.F., Tunkey, C., et al. (2012). Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model. Proc. Natl. Acad. Sci. USA 109, 7859-7864. https://doi.org/10.1073/pnas.1114718109
- Li, D., Peng, X., Yan, D., Tang, H., Huang, F., Yang, Y., and Peng, Z. (2011). Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann. Surg. Oncol. 18, 2074-2083. https://doi.org/10.1245/s10434-011-1567-9
- Linder, P., and Jankowsky, E. (2011). From unwinding to clamping - the DEAD box RNA helicase family. Nat. Rev. Mol. Cell Biol. 12, 505-516. https://doi.org/10.1038/nrm3154
- Lindqvist, L., Oberer, M., Reibarkh, M., Cencic, R., Bordeleau, M.E,. Vogt, E., Marintchev, A., Tanaka, J., Fagotto, F., Altmann, M., et al. (2008). Selective pharmacological targeting of a DEAD box RNA helicase. PLoS One 3, e1583. https://doi.org/10.1371/journal.pone.0001583
- Liu, D.C., Yang, Z.L., and Jiang, S. (2010). Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Cancer Biomark 8, 113-121.
- Lorkovic, Z.J. (2012). RNA binding proteins. Austin, Tex., Landes Bioscience.
- Moghbeli, M., Forghanifard, M.M., Aarabi, A., Mansourian, A., and Abbaszadegan, M.R. (2013). Clinicopathological sex- related relevance of Musashi1 mRNA expression in esophageal squamous cell carcinoma patients. Pathol. Oncol Res. [Epub ahead of print]
- Muto, J., Imai, T., Ogawa, D., Nishimoto, Y., Okada, Y., Mabuchi, Y., Kawase, T., Iwanami, A., Mischel, P.S., Saya, H., et al. (2012). RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways. PLoS One 7, e33431. https://doi.org/10.1371/journal.pone.0033431
- Nakamura, M., Okano, H., Blendy, J.A., and Montell, C. (1994). Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development. Neuron 13, 67-81. https://doi.org/10.1016/0896-6273(94)90460-X
- Nakano, A., Kanemura, Y., Mori, K., Kodama, E., Yamamoto, A., Sakamoto, H., Nakamura, Y., Okano, H., Yamasaki, M., and Arita, N. (2007). Expression of the Neural RNA-binding protein Musashi1 in pediatric brain tumors. Pediatr. Neurosurg. 43, 279-284. https://doi.org/10.1159/000103307
- Northcott, P.A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C.G., Mack, S., Bouffet, E., Clifford, S.C., Hawkins, C.E., French, P., et al. (2011). Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 29, 1408-1414. https://doi.org/10.1200/JCO.2009.27.4324
- Northcott, P.A., Korshunov, A., Pfister, S.M., and Taylor, M.D. (2012a). The clinical implications of medulloblastoma subgroups. Nat. Rev. Neurol. 8, 340-351. https://doi.org/10.1038/nrneurol.2012.78
- Northcott, P.A., Shih, D.J., Peacock, J., Garzia, L., Morrissy, A.S., Zichner, T., Stutz, A.M., Korshunov, A., Reimand, J., Schumacher, S.E., et al. (2012b). Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49-56. https://doi.org/10.1038/nature11327
- Owsianka, A.M., and Patel, A.H. (1999). Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257, 330-340. https://doi.org/10.1006/viro.1999.9659
- Packer, R.J., and Vezina, G. (2008). Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch. Neurol. 65, 1419-1424. https://doi.org/10.1001/archneur.65.11.1419
- Pei, Y., Moore, C.E., Wang, J., Tewari, A.K., Eroshkin, A., Cho, Y.J., Witt, H., Korshunov, A., Read, T.A., Sun, J.L., et al. (2012). An animal model of MYC-driven medulloblastoma. Cancer Cell 21, 155-167. https://doi.org/10.1016/j.ccr.2011.12.021
- Pek, J.W., and Kai, T. (2011). DEAD-box RNA helicase Belle/DDX3 and the RNA interference pathway promote mitotic chromosome segregation. Proc. Natl. Acad. Sci. USA 108, 12007-12012. https://doi.org/10.1073/pnas.1106245108
- Pugh, T.J., Weeraratne, S.D., Archer, T.C., Pomeranz Krummel, D. A., Auclair, D., Bochicchio, J., Carneiro, M.O., Carter, S.L., Cibulskis, K., Erlich, R.L., et al. (2012). Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106-110. https://doi.org/10.1038/nature11329
- Puliyappadamba, V.T., Wu, W., Bevis, D., Zhang, L., Polin, L., Kilkuskie, R., Finley, R.L. Jr., Larsen, S.D., Levi, E., Miller, F.R., et al. (2011). Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis. J. Biol. Chem. 286, 38000-38017. https://doi.org/10.1074/jbc.M111.222398
- Putnam, A.A., and Jankowsky, E. (2013). DEAD-box helicases as integrators of RNA, nucleotide and protein binding. Biochim. Biophys. Acta 1829, 884-893. https://doi.org/10.1016/j.bbagrm.2013.02.002
- Radi, M., Falchi, F., Garbelli, A., Samuele, A., Bernardo, V., Paolucci, S., Baldanti, F., Schenone, S., Manetti, F., Maga, G., et al. (2012). Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. Bioorg. Med. Chem. Lett. 22, 2094-2098. https://doi.org/10.1016/j.bmcl.2011.12.135
- Raffel, C., Jenkins, R.B., Frederick, L., Hebrink, D., Alderete, B., Fults, D.W., and James, C.D. (1997). Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 57, 842-845.
- Reifenberger, J., Wolter, M., Weber, R.G., Megahed, M., Ruzicka, T., Lichter, P., and Reifenberger, G. (1998). Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 58, 1798-1803.
- Remke, M., Hielscher, T., Korshunov, A., Northcott, P.A., Bender, S., Kool, M., Westermann, F., Benner, A., Cin, H., Ryzhova, M., et al. (2011). FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J. Clin. Oncol. 29, 3852-3861. https://doi.org/10.1200/JCO.2011.36.2798
- Remke, M., Ramaswamy, V., Peacock, J., Shih, D.J., Koelsche, C., Northcott, P.A., Hill, N., Cavalli, F.M., Kool, M., Wang, X., et al. (2013). TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol. 126, 917-929. https://doi.org/10.1007/s00401-013-1198-2
- Richter, K., Good, P.J., and Dawid, I.B. (1990). A developmentally regulated, nervous system-specific gene in Xenopus encodes a putative RNA-binding protein. New Biol. 2, 556-565.
- Rishi, A.K., Zhang, L., Boyanapalli, M., Wali, A., Mohammad, R.M., Yu, Y., Fontana, J.A., Hatfield, J.S., Dawson, M.I., Majumdar, A.P., et al. (2003). Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437. J. Biol. Chem. 278, 33422-33435. https://doi.org/10.1074/jbc.M303173200
- Rishi, A.K., Zhang, L., Yu, Y., Jiang, Y., Nautiyal, J., Wali, A., Fontana, J.A., Levi, E., and Majumdar, A.P. (2006). Cell cycleand apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor. J. Biol. Chem. 281, 13188-13198. https://doi.org/10.1074/jbc.M512279200
- Robinson, G., Parker, M., Kranenburg, T.A., Lu, C., Chen, X., Ding, L., Phoenix, T.N., Hedlund, E., Wei, L., Zhu, X., et al. (2012). Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43-48. https://doi.org/10.1038/nature11213
- Sakakibara, S., and Okano, H. (1997). Expression of neural RNAbinding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J. Neurosci. 17, 8300-8312.
- Sakakibara, S., Imai, T., Hamaguchi, K., Okabe, M., Aruga, J., Nakajima, K., Yasutomi, D., Nagata, T., Kurihara, Y., Uesugi, S., et al. (1996). Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev. Biol. 176, 230-242. https://doi.org/10.1006/dbio.1996.0130
- Sanchez-Diaz, P.C., Burton, T.L., Burns, S.C., Hung, J.Y., and Penalva, L.O. (2008). Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC Cancer 8, 280. https://doi.org/10.1186/1471-2407-8-280
- Sawyers, C. (2004). Targeted cancer therapy. Nature 432, 294-297. https://doi.org/10.1038/nature03095
- Scherrer, T., Mittal, N., Janga, S.C., and Gerber, A.P. (2010). A screen for RNA-binding proteins in yeast indicates dual functions for many enzymes. PLoS One 5, e15499. https://doi.org/10.1371/journal.pone.0015499
- Schiffner, S., Zimara, N., Schmid, R., and Bosserhoff, A.K. (2011). p54nrb is a new regulator of progression of malignant melanoma. Carcinogenesis 32, 1176-1182. https://doi.org/10.1093/carcin/bgr103
- Schroder, M. (2010). Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem. Pharmacol. 79, 297-306. https://doi.org/10.1016/j.bcp.2009.08.032
- Schroder, M. (2011). Viruses and the human DEAD-box helicase DDX3: inhibition or exploitation? Biochem. Soc. Trans. 39, 679-683. https://doi.org/10.1042/BST0390679
- Schuller, U., Heine, V.M., Mao, J., Kho, A.T., Dillon, A.K., Han, Y.G., Huillard, E., Sun, T., Ligon, A.H., Qian, Y., et al. (2008). Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 14, 123-134. https://doi.org/10.1016/j.ccr.2008.07.005
- Schwanhausser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., and Selbach, M. (2011). Global quantification of mammalian gene expression control. Nature 473, 337-342. https://doi.org/10.1038/nature10098
- Smoll, N.R. (2012). Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs). Cancer 118, 1313-1322. https://doi.org/10.1002/cncr.26387
- Soto-Rifo, R., Rubilar, P.S., Limousin, T., de Breyne, S., Decimo, D., and Ohlmann, T. (2012). DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J. 31, 3745-3756. https://doi.org/10.1038/emboj.2012.220
- Soulat, D., Burckstummer, T., Westermayer, S., Goncalves, A., Bauch, A., Stefanovic, A., Hantschel, O., Bennett, K.L., Decker, T., and Superti-Furga, G. (2008). The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27, 2135-2146. https://doi.org/10.1038/emboj.2008.126
- Sugiyama-Nakagiri, Y., Akiyama, M., Shibata, S., Okano, H., and Shimizu, H. (2006). Expression of RNA-binding protein Musashi in hair follicle development and hair cycle progression. Am. J. Pathol. 168, 80-92. https://doi.org/10.2353/ajpath.2006.050469
- Sun, M., Zhou, T., Jonasch, E., and Jope, R.S. (2013). DDX3 regulates DNA damage-induced apoptosis and p53 stabilization. Biochim. Biophys. Acta 1833, 1489-1497. https://doi.org/10.1016/j.bbamcr.2013.02.026
- Sureban, S.M., May, R., George, R.J., Dieckgraefe, B.K., McLeod, H.L., Ramalingam, S., Bishnupuri, K.S., Natarajan, G., Anant, S., and Houchen, C.W. (2008). Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology 134, 1448-1458. https://doi.org/10.1053/j.gastro.2008.02.057
- Thompson, M.C., Fuller, C., Hogg, T.L., Dalton, J., Finkelstein, D., Lau, C.C., Chintagumpala, M., Adesina, A., Ashley, D.M., Kellie, S.J., et al. (2006). Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J. Clin. Oncol. 24, 1924-1931. https://doi.org/10.1200/JCO.2005.04.4974
- Toda, M., Iizuka, Y., Yu, W., Imai, T., Ikeda, E., Yoshida, K., Kawase, T., Kawakami, Y., Okano, H., and Uyemura, K. (2001). Expression of the neural RNA-binding protein Musashi1 in human gliomas. Glia 34, 1-7. https://doi.org/10.1002/glia.1034
- Tsvetanova, N.G., Klass, D.M., Salzman, J., and Brown, P.O. (2010). Proteome-wide search reveals unexpected RNA-binding proteins in Saccharomyces cerevisiae. PLoS One 5, pii: e12671. https://doi.org/10.1371/journal.pone.0012671
- Vo, D.T., Subramaniam, D., Remke, M., Burton, T.L., Uren, P.J., Gelfond, J.A., de Sousa Abreu, R., Burns, S.C., Qiao, M., Suresh, U., et al. (2012). The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. Am. J. Pathol. 181, 1762-1772. https://doi.org/10.1016/j.ajpath.2012.07.031
- Vogel, C., Abreu Rde, S., Ko, D., Le, S.Y., Shapiro, B.A., Burns, S.C., Sandhu, D., Boutz, D.R., Marcotte, E.M., and Penalva, L.O. (2010). Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol. Syst. Biol. 6, 400.
- Wang, X.Y., Yin, Y., Yuan, H., Sakamaki, T., Okano, H., and Glazer, R.I. (2008). Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways. Mol. Cell. Biol. 28, 3589-3599. https://doi.org/10.1128/MCB.00040-08
- Wang, X.Y., Penalva, L.O., Yuan, H., Linnoila, R.I., Lu, J., Okano, H., and Glazer, R.I. (2010). Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol. Cancer 9, 221. https://doi.org/10.1186/1476-4598-9-221
- Wang, X.Y., Yu, H., Linnoila, R.I., Li, L., Li, D., Mo, B., Okano, H., Penalva, L.O., and Glazer, R.I. (2013). Musashi1 as a potential thera- peutic target and diagnostic marker for lung cancer. Oncotarget 4, 739-750.
- Wilkie, G.S., Dickson, K.S., and Gray, N.K. (2003). Regulation of mRNA translation by 5'- and 3'-UTR-binding factors. Trends Biochem. Sci. 28, 182-188. https://doi.org/10.1016/S0968-0004(03)00051-3
- Wilson, D., Pethica, R., Zhou, Y., Talbot, C., Vogel, C., Madera, M., Chothia, C., and Gough, J. (2009). SUPERFAMILY--sophisticated comparative genomics, data mining, visualization and phylogeny. Nucleic Acids Res. 37, D380-386. https://doi.org/10.1093/nar/gkn762
- Yang, Z.J., Ellis, T., Markant, S.L., Read, T.A., Kessler, J.D., Bourboulas, M., Schuller, U., Machold, R., Fishell, G., Rowitch, D.H., et al. (2008). Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14, 135-145. https://doi.org/10.1016/j.ccr.2008.07.003
- Yauch, R.L., Dijkgraaf, G.J., Alicke, B., Januario, T., Ahn, C.P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C.A., Tang, T., et al. (2009). Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326, 572-574. https://doi.org/10.1126/science.1179386
- Yedavalli, V.S., Neuveut, C., Chi, Y.H., Kleiman, L., and Jeang, K.T. (2004). Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119, 381-392. https://doi.org/10.1016/j.cell.2004.09.029
- Yokota, N., Mainprize, T.G., Taylor, M.D., Kohata, T., Loreto, M.,Ueda, S., Dura, W., Grajkowska, W., Kuo, J.S., and Rutka, J.T.(2004). Identification of differentially expressed and developmentallyregulated genes in medulloblastoma using suppressionsubtraction hybridization. Oncogene 23, 3444-3453. https://doi.org/10.1038/sj.onc.1207475
- Zhou, J., Shum, K.T., Burnett, J.C., and Rossi, J.J. (2013). Nanoparticle-based delivery of RNAi therapeutics: progress and challenges. Pharmaceuticals 6, 85-107. https://doi.org/10.3390/ph6010085
Cited by
- Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma vol.47, pp.9, 2015, https://doi.org/10.1038/ng.3358
- Neural stem and progenitor cell fate transition requires regulation of Musashi1 function vol.15, pp.1, 2015, https://doi.org/10.1186/s12861-015-0064-y
- ceRNA in cancer: possible functions and clinical implications vol.52, pp.10, 2015, https://doi.org/10.1136/jmedgenet-2015-103334
- Identification and in silico analysis of cattle DExH/D box RNA helicases vol.5, pp.1, 2016, https://doi.org/10.1186/s40064-015-1640-0
- 4β-Hydroxywithanolide E Modulates Alternative Splicing of Apoptotic Genes in Human Hepatocellular Carcinoma Huh-7 Cells vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-07472-6
- The DEAD-Box RNA Helicase DDX3 Interacts with m 6 A RNA Demethylase ALKBH5 vol.2017, pp.None, 2014, https://doi.org/10.1155/2017/8596135
- Analysis of NRAS RNA G-quadruplex binding proteins reveals DDX3X as a novel interactor of cellular G-quadruplex containing transcripts vol.46, pp.21, 2014, https://doi.org/10.1093/nar/gky861
- DEAD-box RNA helicases Dbp2, Ded1 and Mss116 bind to G-quadruplex nucleic acids and destabilize G-quadruplex RNA vol.55, pp.31, 2014, https://doi.org/10.1039/c8cc10091h
- LncRNA FENDRRattenuates adriamycin resistance via suppressingMDR1 expression through sponging HuR and miR‐184 in chronic myelogenous leukaemia cells vol.593, pp.15, 2014, https://doi.org/10.1002/1873-3468.13480
- Decoding competing endogenous RNA networks for cancer biomarker discovery vol.21, pp.2, 2014, https://doi.org/10.1093/bib/bbz006
- The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma vol.20, pp.1, 2014, https://doi.org/10.1186/s12935-020-01581-5
- A novel machine learning derived RNA-binding protein gene-based score system predicts prognosis of hepatocellular carcinoma patients vol.9, pp.None, 2014, https://doi.org/10.7717/peerj.12572
- MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways vol.122, pp.12, 2014, https://doi.org/10.1002/jcb.30153